The role of collagen-derived proteolytic fragments in angiogenesis

Matrix Biology

Volumn 20, Issue 5-6, 2001, Pages 337-345

  Marneros, A G ^a   Olsen, B R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Basement membrane; Collagen IV; Collagen XV; Collagen XVIII; Endostatin

Indexed keywords

ANGIOGENESIS INHIBITOR; COLLAGEN; COLLAGEN TYPE 15; COLLAGEN TYPE 18; COLLAGEN TYPE 4; ENDOSTATIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; BASEMENT MEMBRANE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; DRUG ACTIVITY; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SHORT SURVEY; TUMOR GROWTH;

ANIMALS; COLLAGEN; COLLAGEN TYPE IV; COLLAGEN TYPE XVIII; ENDOSTATINS; HUMANS; HYDROLYSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY;

EID: 0034848340     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(01)00151-2     Document Type: Short Survey

References (68)

1. The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance
2. Attachment of cells to basement membrane collagen type IV
3. Integrin alpha V beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
4. Mechanisms of angiogenesis and arteriogenesis
5. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
6. The basement membrane glycoprotein entactin promotes cell attachment and binds calcium ions
7. Anti-angiogenic cues from vascular basement membrane collagen
8. An alpha2 beta1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix
9. Endostatin induces endothelial cell apoptosis
10. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis
11. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
12. Secreted cathepsin L generates endostatin from collagen XVIII
13. Generation and degradation of human endostatin proteins by various proteinases
14. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
15. Cloning of mouse type XV collagen sequences and mapping of the corresponding gene to 4B1-3. Comparison of mouse and human alpha 1 (XV) collagen sequences indicates divergence in the number of small collagenous domains
16. Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney
17. Collagen XVIII is a basement membrane heparan sulfate proteoglycan
18. A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells
19. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution
20. Novel glycosylated forms of human plasma endostatin and circulating endostatin-related fragments of collagen XV
21. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
22. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
23. Cell surface glypicans are low-affinity endostatin receptors
24. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin
25. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase
26. Primary structure of the alpha 1 chain of human type XV collagen and exon-intron organization in the 3′ region of the corresponding gene
27. Distribution of type XV collagen transcripts in human tissue and their production by muscle cells and fibroblasts
28. Basement membrane (type IV) collagen
29. Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain
30. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells
31. Distinct antitumor properties of a type IV collagen domain derived from basement membrane
32. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin
33. The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes
34. The human alpha 1(XV) collagen chain contains a large amino-terminal non-triple helical domain with a tandem repeat structure and homology to alpha 1(XVIII) collagen
35. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones
36. Type XV collagen exhibits a widespread distribution in human tissues but a distinct localization in basement membrane zones
37. Identification of a previously unknown human collagen chain, alpha 1(XV), characterized by extensive interruptions in the triple-helical region
38. Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis
39. Modulation of angiogenesis in vitro by laminin-entactin complex
40. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
41. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins
42. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21
43. Collagens
44. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo
45. Antiangiogenic activity of restin, NC10 domain of human collagen XV: Comparison to endostatin
46. Local endostatin treatment of gliomas administered by microencapsulated producer cells
47. Identification of three N-terminal ends of type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts
48. Interaction of endostatin with integrins implicated in angiogenesis
49. Mechanisms of angiogenesis
50. Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts
51. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans
52. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
53. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
54. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity
55. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
56. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins
57. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome)
58. Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3)
59. Identification of CD47/integrin-associated protein and alpha(V)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells
60. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
61. Antiangiogenesis signals by endostatin
62. Isolation and characterization of the circulating form of human endostatin
63. The role of the main noncollagenous domain (NC1) in type IV collagen self-assembly
64. The effect of non-enzymatic glucosylation on the binding of the main non-collagenous NC1 domain to type IV collagen
65. Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen
66. Characterization of a type IV collagen major cell binding site with affinity to the alpha beta 1 and the alpha 2 beta 1 integrins
67. The generation of endostatin is mediated by elastase
68. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding